| 中文名 | N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
|---|---|
| 英文名 | N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| 中文别名 |
N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺
n-甲基-n-[(3r,4r)-4-甲基-3-哌啶基]-7H-吡咯并[2,3-d]嘧啶-4-胺 托伐替尼杂质M |
| 英文别名 |
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity M |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 分子式 | C13H19N5 |
| 分子量 | 245.324 |
| 精确质量 | 245.164047 |
| PSA | 56.84000 |
| LogP | 1.54 |
| 折射率 | 1.637 |
| 储存条件 | 2-8°C,避光,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|
|
~92%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |